0% found this document useful (0 votes)
52 views38 pages

Chapter 9-Whole Blood

This chapter discusses whole blood, blood components, and derivatives used in transfusions, outlining their preparation, storage, and clinical indications. It covers various blood products such as packed red cells, plasma products, platelet concentrates, and immunoglobulins, emphasizing the importance of component therapy for effective treatment. The chapter also includes learning objectives and review questions to reinforce understanding of the material.
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd
0% found this document useful (0 votes)
52 views38 pages

Chapter 9-Whole Blood

This chapter discusses whole blood, blood components, and derivatives used in transfusions, outlining their preparation, storage, and clinical indications. It covers various blood products such as packed red cells, plasma products, platelet concentrates, and immunoglobulins, emphasizing the importance of component therapy for effective treatment. The chapter also includes learning objectives and review questions to reinforce understanding of the material.
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd

CHPTER -NINE

Whole Blood ,Blood Components


and Derivatives

CH
Acknowledgements

 Addis Ababa University

 Jimma University

 Hawassa University

 Haramaya University

 University of Gondor

 American Society for clinical Pathology

 Center for Disease Control and Prevention Ethiopia


Content

 Whole blood,
 Packed red cell
 Plasma products
 Platelet concentrates
 Cryoprecipitate
 Albumin
 Immunoglobulin

3
Learning objectives

At the end of this chapter, the student will be able


to:
 Identify the different blood components and
derivatives used in transfusion
 Mention the clinical indications for blood
component transfusion.

4
9.1 Whole blood, blood components and
derivatives
 Only human blood and its components are used
for transfusion into humans
 Transfusions are the introduction of either
 Whole blood

 blood components (RBCs, Plts, plasma or WBCs ) or

 blood derivatives (albumin, gamma globulin, Factors


VII,VIII,Von willebrand,or Immune globulins and
prothrombin) directly into the blood stream.

5
Whole blood….

 Whole blood- complex tissue ,composed of


cells and plasma

 Blood components-prepared from blood by


mechanical method especially by centrifugation

 Blood derivatives-separated by more complex


process (Filteration,Adsorption)

6
Whole blood….

 Component therapy gives a better form of


treatment :

 Minimizes the risk of immune reactions

 Often permits considerable economy in the use of


blood

7
9.2 Whole blood (w/b)

 Contains all cellular elements and coagulation


factors
 Freshly drawn w/b maintains all its properties for
a limited time.
 Upon storage a number of changes occur,

Example:
 increase in O2 affinity and
 loss of viability of RBC.
8
Indications for whole blood

 To provide both:
 O2 carrying capacity and
 blood volume expansion
Example In the treatment of massive hemorrhage.
 Used as a source material for blood component
preparation.
 For exchange transfusion in new born.
 Whole blood less than 4-5 days old is often the blood
of choice

9
Blood components

10
Blood components..

 Component make blood use more economical


by using one unit one can treat:-

 Anemia with the packed cells

 Platelet deficiency with platelet preparations

 Clotting factor and other plasma deficiencies

11
[Link] cell preparation

 Is the product remaining after the removal of


most of the plasma from freshly drawn whole
blood by centrifugation.

 The commonly available RBC preparations are


 Concentrated red cell suspension
 Frozen/ Deglycerolized red cells
 Leukocyte poor red cell suspension

12
Red cell preparation….

 The red cell prepared in this form contain the


same:
 redcell mass and
 oxygen carrying capacity as whole blood with
approximately one half of the volume.

 The final Hematocrit of the product should be


between 70-80% in 250-300 ml of volume

13
Red cell preparation…

 Concentrated red cell (CRC) is used to treat


patients with symptomatic anemia

 Transfusion of 1 unit red cell increases the Hct


by 3% and the hemoglobin by 1 gm.

14
9.4. Plasma products

 Plasma is a fluid portion of one unit of blood


collected and separated in a closed system
and intended for intra venous use.

 The therapeutically useful plasma products


are:
 Fresh Frozen plasma (FFP)
 Ordinary plasma (OP)/ single donor plasma
 Cryodepleted plasma

 All plasma products have to be stored at -180C


or colder
15
Plasma products….

Fresh Frozen plasma (FFP)


 Is the plasma obtained from a unit of whole
blood after centrifugation

 It is then separated and frozen solid at a


temperature that will adequately maintain the
labile coagulation factors in a functional state.

16
Plasma products….

 The indications for FFP are for:


 replacement of coagulation factors
 labile ( Factors V and VIII) and
 stable (fibrinogen, VII, X, XI)
 deficiencies of anti-thrombin III
 deficiencies of protein C and protein S
 treatment of thrombotic thrombocytopenic
purpura (TTP)

17
Plasma products….

FFP
 Should be stored frozen at –300C or colder for
12 months
 beyond this period the factors VII may have
decreased
 To maintain adequate levels of coagulation factors

 If not used in 12 months time may be re


designated and relabeled ”Plasma” and has 4
more years of shelf life at –180C or colder.

18
Single donor plasma (SDP) / ordinary plasma(OP)

 Is deficient in labile coagulation factors.

 It is separated from single whole blood unit at


any time during its storage and up to 5 days
after the expiration of the original unit.

19
plasma….

 OP is different from FFP in that it contains high


levels of K and ammonia since it is prepared
after long contact with red cells

 is stable up to 5 years after preparation if kept


frozen at-180C or colder.

20
plasma…..

 Indications:

 Inthe treatment of stable coagulation factors


deficiencies

 For volume and protein replacement under special


circumstances

21
plasma…..

Cryo-depleted plasma (CDP)


 CDP is the supernatant plasma following
removal of cryoprecipitate
 albumin, immunoglobulin and coagulation factors are
the same as that of FFP,
 fibrinogen concentration and levels of the labile
coagulation factors V and VIII are markedly reduced.

22
Plasma…..

 CDP is indicated for patients requiring volume


expansion or protein replacement when labile
clotting factors are not required

23
[Link] concentrates (PC)

 Is conversion of whole blood into concentrated


red cells with in the first 6 hours of collection.

 PC from random donations are the most


frequently used form of platelet product.
(“random” platelet)

24
Platelet …….

 Each unit of PC
 contains 5.5x1010 platelet in 50-65ml of plasma
 represents 60-80% of the platelet present in a unit of
whole blood.
 increases the platelet count by approximately 5,000-
10,000 / ml in an average adult.

 The normal adult dose is 6-10 units, and for


child 1 unit/ 10kg

25
Platelet …….

 Platelet should be stored at:


 1-60C with agitation for 72 hours if prepared in a close
system
 20-240C for
 24 hours if prepared in an open system
 5 days if prepared in closed system

 Refrigerated PC don’t maintain function or


viability as well as the PC stored at room
temperature.
26
Platelet …….

Indications

 Patients who are actively bleeding from


thrombocytopenia

 due to drugs, toxins, infections and bone marrow


failure

 Bleeding caused from qualitatively abnormal


platelet.
27
[Link] and Rh compatibility in platelet
transfusions
 PC of the same ABO group should be used

 Rh (D) incompatibility has no effect on platelet


survival
 but the extent of RBC contaminating in PC may be
sufficient to immunize Rh (D) negative women in
reproductive age group.

 In such cases Rh (D) negative PC should be given

28
[Link] (CRyo)

 Is a cold- precipitated concentration of factor


VIII, anti hemophilic factor (AHF), obtained after
the plasma has been thawed.
 Contains:
 Factor VIII: C (pro coagulation factor)
 Factor VIII: VWF (Von-Willebrand’s factors)
 Fibrinogen factor XIII
 Fibronectin factor

29
(CRyo)…

 Each unit has at least 80μl of factor VIII, 250 mg


of fibrinogen in a volume of 15 to 20 ml.

 Cryo:

 has a shelf life of 12 months at a temperature of-180C


or colder (preferably-300C) and
 it must be transfused within 6 hours after thawing at
370C.

30
(CRyo)……..

Indications
 In the management of classic hemophilia (factor
VIII deficiency)
 In the management of factor XIII deficiency
 In the management of von willebrand’s disease
and
 source of fibrinogen for the treatment of hypo
fibrinogenemia.

31
[Link]
 Is the most abundant of the plasma proteins.

 Provides the critical colloid osmotic or oncotic


pressure that regulates the passage of water
through the capillaries

 Abnormally low levels of Albumin will result in


excessive leakage of fluid in the tissues known
as edema.

32
Albumin…
Indications
 Albumin is available in either 5% or 25% solution
osmotically equivalent to normal plasma.

 Transfused to replace proteins and fluids


 in burn patients and
 in cases of shock due to hemorrhage or surgery.

 Also administered for adult respiratory distress


syndrome and in cases of liver failure.
33
[Link](Ig)

 Among the plasma proteins, the Ig or antibodies


are second only to albumin in concentration.

 The Ig are commonly divided into five classes


designated as IgA, IgG, IgM, IgE, and IgD.

34
Immunoglobulins…

Indications
 IgG are commonly used in a number of vaccines
including
• TIG (Tetanus immune globulin)
• HBIG, (Hepatitis B immune globulin)
• VZIG (Varicella zoster immune globulin) and
• RIG (Rabies immune globulin)

 Igs are administered both intravenously and


intramuscularly (as injections) depending upon
the type.
35
Review questions

1. Name the common blood components that can


be prepared from a unit of donated blood.
2. Describe the clinical indications for transfusion
of the different blood components.
3. What is OP? Describe its use.
4. What are the optimum storage temperatures of
plasma products?

36
References

[Link] for medical laboratory


science students,Yayehyirad T. and Misganaw
B., Upgraded lecture note.2008
[Link] and applied concepts of
Immunohematology, 2nd ed. Kathy [Link]
and Paula [Link],2009
3. Blood banking and transfusion medicine: basic
principles and practice. Christopher [Link] et
al., 2nd ed.2007.
[Link]
37
blood donations, Module 1 WHO.2002
References…

[Link] for HIV and other infectious agents,


Module 2, WHO. 2002
[Link] group serology. Module 3 WHO.2002
[Link] and principles for safe blood
transfusion practice, Introductory module. WHO
2002.
[Link]: Principles and Practice
Quinley. 2nd ed.1998.
[Link] Technical Manual .15th Edition.2005
38

You might also like